Skip to content
Brand AI

Luye Pharma

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2016

    Subsidiary Fined and Confiscated RMB 3.64 Million for Producing Substandard Ginkgo Leaf Capsules

    In 2016, Wuhu Luye Pharmaceutical, which had an equity connection to Luye Pharma founder Liu Dianbo, was fined and confiscated approximately RMB 3.6428 million by the Anhui Provincial Food and Drug Administration for illegally producing and selling substandard ginkgo leaf capsules by improperly altering the extraction process; its Xiao'er Kechuanling Granules were also deemed inferior drugs and penalized. The incident occurred during the 2015 rectification of the ginkgo leaf extract industry.

    Source